fulvestrant has been researched along with glucagon-like peptide 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abderrahmani, A; Bosco, D; Cornu, M; Jacovetti, C; Jonas, JC; Laybutt, R; Meugnier, E; Parnaud, G; Peyot, ML; Prentki, M; Regazzi, R; Rome, S; Thorens, B | 1 |
1 other study(ies) available for fulvestrant and glucagon-like peptide 1
Article | Year |
---|---|
MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity.
Topics: Adaptation, Physiological; Animals; Cells, Cultured; Cytokines; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Insulin Resistance; Islets of Langerhans; Male; Mice; Mice, Mutant Strains; MicroRNAs; Obesity; Organ Size; Postpartum Period; Pregnancy; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Glucagon; Signal Transduction | 2012 |